Jounce Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Jounce Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2015 to 2022.
  • Jounce Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $590K, a 24.8% decline year-over-year.
  • Jounce Therapeutics, Inc. annual Depreciation for 2022 was $2.09M, a 26.2% decline from 2021.
  • Jounce Therapeutics, Inc. annual Depreciation for 2021 was $2.83M, a 16.9% decline from 2020.
  • Jounce Therapeutics, Inc. annual Depreciation for 2020 was $3.4M, a 11.7% decline from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.09M -$740K -26.2% Jan 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
2021 $2.83M -$574K -16.9% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 $3.4M -$450K -11.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $3.85M +$20K +0.52% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $3.83M -$591K -13.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $4.42M +$2.48M +127% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $1.94M +$474K +32.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $1.47M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.